Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel). Клиническая онкогематология 2023, 16 (2), 227-228. https://doi.org/10.21320/6nkr3a68.